{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:20:03Z","timestamp":1777486803739,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4794,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1016\/s1074-7613(00)80218-6","type":"journal-article","created":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T09:50:07Z","timestamp":1083405007000},"page":"677-686","source":"Crossref","is-referenced-by-count":389,"title":["CD4 + T Cell\u2013Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFN\u03b3 Receptor Expression by Nonhematopoietic Cells"],"prefix":"10.1016","volume":"12","author":[{"given":"Zhihai","family":"Qin","sequence":"first","affiliation":[]},{"given":"Thomas","family":"Blankenstein","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1074-7613(00)80218-6_BIB1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","article-title":"The IFN gamma receptor","volume":"15","author":"Bach","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.173.3.647","article-title":"Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes","volume":"173","author":"Barth","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic-T-cell responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.173.5.1047","article-title":"Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer","volume":"173","author":"Blankenstein","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB7","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.4049\/jimmunol.158.6.2834","article-title":"Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation","volume":"158","author":"Cayeux","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80585-3","article-title":"Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis","volume":"9","author":"Coughlin","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/1074-7613(94)90087-6","article-title":"Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors","volume":"1","author":"Dighe","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB10","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB11","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1073\/pnas.87.14.5238","article-title":"A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines","volume":"87","author":"Farber","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev.iy.11.040193.003035","article-title":"The molecular cell biology of interferon-gamma and its receptor","volume":"11","author":"Farrar","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB13","doi-asserted-by":"crossref","first-page":"9064","DOI":"10.1073\/pnas.95.16.9064","article-title":"Antiangiogenic gene therapy","volume":"95","author":"Folkman","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0277-5379(86)90107-0","article-title":"Recombinant tumor necrosis factor","volume":"22","author":"Fransen","year":"1986","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB15","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.4049\/jimmunol.133.3.1671","article-title":"The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity","volume":"133","author":"Fujiwara","year":"1984","journal-title":"J. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0065-2776(08)60778-6","article-title":"Adoptive T cell therapy of tumors","volume":"49","author":"Greenberg","year":"1991","journal-title":"Adv. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1084\/jem.154.3.952","article-title":"Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes","volume":"154","author":"Greenberg","year":"1981","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1084\/jem.161.5.1122","article-title":"Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells","volume":"161","author":"Greenberg","year":"1985","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/1074-7613(95)90163-9","article-title":"Specific immunity to Listeria monocytogenes in the absence of IFN gamma","volume":"3","author":"Harty","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB20","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1073\/pnas.86.24.9901","article-title":"Cloning of murine interferon gamma receptor cDNA","volume":"86","author":"Hemmi","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1084\/jem.174.6.1291","article-title":"Interleukin 7 induces CD4+ T cell-dependent tumor rejection","volume":"174","author":"Hock","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB22","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1073\/pnas.90.7.2774","article-title":"Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma","volume":"90","author":"Hock","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.7513904","article-title":"Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens","volume":"264","author":"Huang","year":"1994","journal-title":"Science"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB24","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB25","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","article-title":"The central role of CD4(+) T cells in the antitumor immune response","volume":"188","author":"Hung","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1084\/jem.179.4.1215","article-title":"In vivo priming of two distinct antitumor effector populations","volume":"179","author":"Levitsky","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0167-5699(99)01450-4","article-title":"Specific and nonspecific immunity in the prevention of spontaneous tumours","volume":"20","author":"Lollini","year":"1999","journal-title":"Immunol. Today"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/315672a0","article-title":"Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins","volume":"315","author":"Luster","year":"1985","journal-title":"Nature"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/1074-7613(95)90078-0","article-title":"A unique tumor antigen produced by a single amino acid substitution","volume":"2","author":"Monach","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB30","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/nar\/18.12.3587","article-title":"Advanced mammalian gene transfer","volume":"18","author":"Morgenstern","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB32","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.1073\/pnas.96.15.8633","article-title":"CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma","volume":"96","author":"Mumberg","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB33","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4049\/jimmunol.134.3.1619","article-title":"Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma","volume":"134","author":"Murray","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.187.5.693","article-title":"Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors","volume":"187","author":"Ossendorp","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB35","first-page":"769","article-title":"Immunity to methylcholanthrene-induced sarcomas","volume":"18","author":"Prehn","year":"1957","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB36","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nm0598-627","article-title":"B cells inhibit induction of T cell-dependent tumor immunity","volume":"4","author":"Qin","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40\u2013CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB39","series-title":"Fundamental Immunology","article-title":"Tumor immunology","author":"Schreiber","year":"1999"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB40","doi-asserted-by":"crossref","first-page":"13791","DOI":"10.1073\/pnas.93.24.13791","article-title":"Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo","volume":"93","author":"Sgadari","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB41","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood.V89.8.2635","article-title":"Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo","volume":"89","author":"Sgadari","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0167-5699(85)90080-5","article-title":"Immune interferon","volume":"6","author":"Trinchieri","year":"1985","journal-title":"Immunol. Today"},{"key":"10.1016\/S1074-7613(00)80218-6_BIB43","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/eji.1830220933","article-title":"Distribution of interferon-gamma receptor in human tissues","volume":"22","author":"Valente","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S1074-7613(00)80218-6_BIB44","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1073\/pnas.80.17.5397","article-title":"Human tumor necrosis factor produced by human B-cell lines","volume":"80","author":"Williamson","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761300802186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761300802186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:42:09Z","timestamp":1682692929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761300802186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S1074761300802186"],"URL":"https:\/\/doi.org\/10.1016\/s1074-7613(00)80218-6","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}